Foundations Investment Advisors, LLC Regeneron Pharmaceuticals, Inc. Transaction History

Foundations Investment Advisors, LLC

3 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q4 2021 Jan 21, 2022	SELL	$543.48 - $670.97 $334,783 - $413,317	-616 Closed	0 $0
Q3 2021 Oct 13, 2021	BUY	$574.03 - $680.96 $69,457 - $82,396	121 Added 24.44%	616 $339,000
Q2 2021 Jul 14, 2021	BUY	$472.8 - $558.54 $234,036 - $276,477	495 New	495 $287,000

1,424

82.1M

835K

1.46M

Ticker REGN
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 107,190,000
Market Cap $115B
Description
Regeneron Pharmaceuticals, Inc. discovers, invents, develops, manufactures, and commercializes medicines for treating various diseases worldwide. The company's products include EYLEA injection to treat wet age-related macular degeneration and diabetic macular edema; myopic choroidal neovascularization; and diabetic retinopathy, as well as macula...

Get notified when there are updates to the investment portfolio of Foundations Investment Advisors, LLC, based on Form 13F filings with the SEC.

Stay updated on Foundations Investment Advisors, LLC with notifications on news.